Phase 2 Brain Cancer Trial, Recruiting NCT05692635 Sponsor: Wake Forest University Health Sciences Condition: Brain Cancer
Back to Brain Cancer

Phase 2 Brain Cancer Trial, Recruiting

NCT05692635
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People diagnosed with a specific type of lung cancer (non-squamous) that is locally advanced, classified as stage IIIA, IIIB, or IIIIC according to standard cancer staging guidelines.
  • People whose lung cancer tissue analysis shows a mixed cell type (adeno-squamous) or results that are not clearly categorised but lean toward squamous are also considered eligible.
  • People who are enrolled and have their first brain MRI scan at around 120 days (plus or minus 10 days) from the start of their radiation therapy for lung cancer — enrolment can happen before or after radiation therapy begins.
  • People with a general health and activity level rated between 0 and 3 on a standard medical scale (ranging from fully active to limited self-care; confirm with trial site).
  • People whose kidneys are functioning at a sufficient level, as measured by a specific blood test result (confirm with trial site for details).
  • People who are safe to undergo a brain MRI scan, as determined by a safety screening checklist completed by relevant medical staff at the trial site.

Who may not be able to join:

  • People who already have confirmed cancer that has spread to the brain, as seen on their initial staging MRI scan.
  • People who are currently pregnant or breastfeeding.
  • People who could potentially become pregnant and do not have a negative pregnancy test taken within 14 days of enrolling in the trial (this requirement does not apply to people who have gone through menopause or have had certain surgeries such as removal of the uterus or ovaries, or have a medically confirmed condition that prevents pregnancy).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Michael Farris, MD, Wake Forest Baptist Comprehensive Cancer Center

Phone: +13367137749

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
30 August 2023
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Central Nervous System Symptoms - Central Nervous System Symptom Scoring Form

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov